1 Division of Experimental Therapeutics, College of Physicians and Surgeons, Columbia University/New York State Psychiatric Institute, New York, NY, USA; Schizophrenia Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA. Electronic address: ps2723@cumc.columbia.edu.
2 Université Grenoble Alpes, Inserm U1216, Grenoble Institut des Neurosciences, CHU Grenoble-Alpes, F-38000, Grenoble, France.
3 Department of Biomedical Engineering, The City College of New York, CUNY, NY, USA.
4 PIA Ciencias Cognitivas, Centro de Investigación en Ciencias Cognitivas, Centro de Psicología Aplicada, Facultad de Psicología, Universidad de, Talca, Chile.
5 Facultad de Ingeniería, Universidad Autónoma de Chile, Talca, Chile.
6 Division of Experimental Therapeutics, College of Physicians and Surgeons, Columbia University/New York State Psychiatric Institute, New York, NY, USA.
7 Division of Experimental Therapeutics, College of Physicians and Surgeons, Columbia University/New York State Psychiatric Institute, New York, NY, USA; Schizophrenia Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA.